Gilead Sciences (GILD)

$66.69 0.10 (0.15%)

16:00 EDT GILD Stock Quote Delayed 30 Minutes

Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?

By William White, InvestorPlace Writer Dec 21, 2023

Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.

Why Is Compugen (CGEN) Stock Up 189% Today?

Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy

7 Healthcare Stocks to invest in for a Healthy Future

Volume:

Previous Close -

Market Cap 83.62B

PE Ratio 190.54

EPS 0.35

Volume (Avg. Vol.) 4.21M

Day's Range $66.01 - $66.93

52-Week Range $62.07 - $87.86

Dividend & Yield $3.00 (4.50%)

GILD Stock Predictions, Articles, and Gilead Sciences News

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

By William White, InvestorPlace Writer Oct 17, 2023

Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

By Larry Ramer, InvestorPlace Contributor Oct 2, 2023

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment

By William White, InvestorPlace Writer Aug 24, 2023

Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor Aug 9, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023

By Ian Bezek, InvestorPlace Contributor Jul 19, 2023

The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.

The 3 Best Biotech Stocks to Buy In July

By Joel Baglole, InvestorPlace Contributor Jul 5, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor Jun 7, 2023

These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor Jun 2, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Analyst Upgrades That Smart Investors Won’t Ignore

By Chris Markoch, InvestorPlace Contributor May 17, 2023

Even the most experienced investors have only so many hours in the day to perform their due diligence. That’s where analyst ratings can be helpful.…

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

By William White, InvestorPlace Writer May 16, 2023

Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares.

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

By John Blankenhorn, InvestorPlace Contributor Apr 25, 2023

Cash rich biotech stocks can survive while most of their peers struggle with rising interest rates. Here are three to watch.

Strong Quant Screens Say These 7 Growth Stocks Are a Buy

By Chris Lau, InvestorPlace Contributor Apr 19, 2023

Stockrover’s quant screen is a grading system that brings up rewarding growth stocks to buy for income investors.

7 Cash-Rich Companies to Invest in During Economic Uncertainty

By Josh Enomoto, InvestorPlace Contributor Feb 26, 2023

Although they’re not necessarily the most exciting enterprises, these cash-rich stocks should keep your portfolio upright.

7 Dividend Stocks to Buy and Hold Forever

By Will Ashworth, InvestorPlace Contributor Dec 21, 2022

If you’re a dividend investor these seven dividend stocks to buy and hold forever are worth considering heading into 2023.